Mitral Regurgitation: PISA, Vena Contracta, Grading & Clinical Pearls

Key Takeaways

• MR is the most prevalent heart valve disorder worldwide
• PISA uses flow convergence radius to estimate regurgitant volume
• Vena contracta width >0.7 cm signals severe mitral regurgitation
• ASE/EACVI guidelines set quantitative thresholds for MR grading
• Early accurate grading enables timely surgery, improving survival

Pulse Analysis

Mitral regurgitation (MR) tops the list of valvular diseases, affecting roughly 2 % of the adult population and appearing on virtually every transthoracic echo. While most sonographers can spot a regurgitant jet, the real challenge lies in quantifying severity—a step that directly influences therapeutic decisions. The American Society of Echocardiography (ASE) and the European Association of Cardiovascular Imaging (EACVI) have converged on a set of quantitative criteria that transform a visual finding into actionable data. Mastering these metrics is now a baseline competency for cardiac imaging labs.

The proximal isovelocity surface area (PISA) method remains the cornerstone for calculating regurgitant volume. By measuring the radius of the hemispheric flow convergence zone and applying the formula 2πr²·Valias, clinicians obtain an objective estimate of effective regurgitant orifice area. Vena contracta, the narrowest jet segment, offers a quicker, angle‑independent surrogate; a width greater than 0.7 cm reliably denotes severe MR. Both techniques complement each other—PISA excels in eccentric jets, while vena contracta shines in central, high‑velocity flows—providing a robust diagnostic toolkit.

Accurate grading translates directly into patient outcomes because surgical referral thresholds hinge on quantitative cut‑offs. Patients identified with severe MR before symptom onset enjoy markedly lower peri‑operative mortality and better long‑term ventricular remodeling. Consequently, training programs now embed PISA and vena contracta modules into core curricula, and many centers are adopting three‑dimensional echo and AI‑driven analytics to streamline measurements. As imaging technology evolves, the ability to deliver precise, reproducible MR severity assessments will remain a pivotal factor in optimizing heart‑team decision making.